Women’s Bodily Autonomy Under Attack: Abortion Rights and the Global Anti-Gender Movement

In recent years, the global conversation around abortion access has intensified, marked by both significant setbacks and unexpected openings for progress. Although restrictive laws in several countries have drawn international concern, a parallel movement is gaining momentum—one focused on expanding reproductive rights through legal reform, clinical innovation, and cross-border solidarity. This editorial examines not only the challenges but also the tangible possibilities for advancing abortion access as a matter of health equity and human dignity.

The overturning of Roe v. Wade in the United States in June 2022 triggered a wave of state-level abortion bans, with 14 states enforcing near-total prohibitions as of early 2024, according to the Guttmacher Institute. These changes have disproportionately affected low-income individuals, people of color, and those in rural areas, who face greater barriers to travel or access medication abortion. Yet, even in this climate, new pathways to care are emerging, driven by telemedicine, self-managed abortion protocols, and advocacy that centers lived experience.

Internationally, the trend is not uniformly regressive. In 2023, Colombia’s Constitutional Court decriminalized abortion up to 24 weeks of pregnancy, building on a 2022 ruling that already allowed the procedure in cases of fetal inviability or risk to maternal health. Similarly, France enshrined the right to abortion in its constitution in March 2024, becoming the first country to do so, a move supported by over 80% of the public in polls conducted by IFOP. These developments reflect a growing recognition that reproductive autonomy is foundational to gender equality and public health.

One of the most promising advances lies in the use of medication abortion—specifically the combination of mifepristone and misoprostol—which the World Health Organization has listed as essential medicines since 2019. When used within the first 12 weeks of pregnancy, this regimen is over 95% effective and carries a lower risk of complications than many common medications, including penicillin and Viagra. Telehealth models that allow patients to consult providers remotely and receive pills by mail have expanded access in places where clinics are scarce, from parts of Australia to Indigenous communities in Canada.

Still, legal and logistical hurdles persist. In the United States, the Alliance for Hippocratic Medicine’s lawsuit challenging FDA approval of mifepristone reached the Supreme Court in 2024, though the Court unanimously upheld the drug’s availability, citing lack of standing by the plaintiffs. The decision was a critical victory for abortion access, yet it did not address broader questions about federal preemption versus state authority, leaving uncertainty for providers and patients alike.

Beyond the clinic, grassroots networks are filling gaps where formal systems fall short. Groups like Las Libres in Mexico and Just the Pill in the United States provide information, financial support, and practical assistance to those seeking abortions, often operating across state or national borders . These efforts underscore a key insight: when legal frameworks fail, community-led care can sustain access—but only if supported by funding, training, and protection from legal reprisal.

The role of international aid also warrants closer scrutiny. While some donor countries have restricted funding for abortion-related services under policies like the expanded Mexico City Policy, others are increasing support. Sweden, for example, allocated over 100 million SEK in 2023 to sexual and reproductive health initiatives in sub-Saharan Africa, including abortion care and post-abortion treatment. Such investments not only save lives but also strengthen health systems by reducing complications from unsafe procedures, which the WHO estimates still account for 5–13% of maternal deaths globally.

Looking ahead, the next major development to watch is the upcoming review of abortion laws by the Indian Supreme Court, scheduled for hearings later in 2024. The court is considering petitions to extend the legal limit for abortion beyond 20 weeks in certain cases, building on the 2022 amendment that already allowed abortions up to 24 weeks for survivors of rape, minors, and women with disabilities. A favorable ruling could significantly expand access for millions in one of the world’s most populous nations.

Progress in abortion access is not inevitable, but it is possible—shaped by legal decisions, medical advances, and the persistent advocacy of those who refuse to accept rollbacks as final. What matters now is ensuring that gains are not isolated victories but part of a broader, durable framework that treats reproductive health as essential, not expendable. For readers seeking reliable updates, the Guttmacher Institute’s state policy tracker and the Center for Reproductive Rights’ abortion law maps offer regularly verified, source-backed information .